A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

Walter Fiedler
Joerg Chromik
Stefanie Amberg
Maxim Kebenko
Felicitas Thol
Vera Schlipfenbacher
Anne Christine Wilke
Franziska Modemann
Melanie Janning
Hubert Serve
Arnold Ganser
Carsten Bokemeyer
Susann Theile
Ute Deppermann
Anne L Kranich
Michael Heuser

Related Research units

II. Department of Medicine

Bibliographical data

Original language	English
ISSN	0007-1048
DOIs	https://doi.org/10.1111/bjh.16804
Publication status	Published - 08.2020

PubMed	32515072

Sitemap | Data protection | Imprint © Universitätsklinikum Hamburg-Eppendorf